Wednesday, March 8, 2017

Women in pharma

International Women's Day

With the world celebrating International Women’s Day, we take a look at women in pharma.

Despite being set to become Big Pharma’s first female CEO, Emma Walmsley at GSK doesn’t see her gender as a major issue: ‘I’ve never primarily defined myself by my gender. I’ve been lucky enough to always work for companies or in countries where being female hasn’t limited or restricted me.’

However, the numbers suggest there is still some way to go before equality in pharma. Prior to Walmsley’s appointment, none of the world’s top 25 drugmakers were led by a woman, and less than 3% of new pharma CEO positions globally were given to women in 2015.

At Boston Biotech Week last year we spoke to President and CEO of Biomedical Growth Strategies Susan Windham-Bannister about the lack of gender diversity in Life Sciences and why organizations should be trying to improve.
For her, gender diversity should be a business strategy issue. Life sciences is one of the fastest growing sectors in the world so ‘the demand for talent is increasing exponentially and they really need to tap into the full complement of available talent’ – including women. Equally, innovation is at the heart of much of pharma, and that ‘requires different opinions and different perspectives, which women bring’. Watch the fascinating full interview above or here.

Women at T3

At the inaugural T3: Trials, Tech and Transformation conference on 11 – 12 May in Orlando 18 of the 40 confirmed speakers are women, including CEOs, directors, presidents and COOs. 

The women speaking at T3 - click to enlarge

Discover the full list of speakers as well as agenda, and register before 3/17 to save up to $400 off standard rates. PLUS use the exclusive code T3BLOG17 to save an additional $200. Find out more here.

No comments: